MTHFD2 and leukemia: As cancers often display increased reliance on MTHFD2 function (187), the findings summarized here emphasize the potential of MTHFD2 targeting in cancer therapy, and indeed, it was shown recently to be a suitable target for inhibition of leukemia growth (41).